Review: New diagnostic and therapeutic avenues for mesothelioma

Pak J Pharm Sci. 2015 Jul;28(4):1425-32.

Abstract

Mesothelioma is a rare form of cancer affecting the mesothelium lining. It is usually caused by asbestos exposure or exposure to nanofibers. Median survival is less than one year in the mesothelioma patients. Due to its severity, there is a dire necessity to find out new diagnostic and therapeutic strategies. Some recent strategies could help us in fighting against mesothelioma. Diagnostic tools include a range of biomarkers or biotechnological procedure. Therapeutic tools include chemotherapeutic strategies along with immunotherapy, gene therapy and alternative therapy.

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Complementary Therapies
  • Genetic Therapy
  • Humans
  • Mesothelioma / diagnosis*
  • Mesothelioma / mortality
  • Mesothelioma / therapy*